Survival of invasive bladder cancer patients, 1998–2009; a central and northern Denmark population-based cohort study

Figures & data

Table 1 1-, 3-, and 5-year survival, and the crude, gender- and age-adjusted 1-, 3-, and 5-year all-cause MRRs in the four time periods. The reference was patients from the period 1998–2000

	Year of diagnosis
	1998–2000	2001–2003	2004–2006	2007–2009
Number of cancer patients	1028	960	965	1079
Median age (years)	73	74	74	74
1 year
Survival	68% (65%–70%)	63% (60%–66%)	64% (61%–67%)	70% (67%–73%)
MRRs	1 (reference)	1.18 (1.02–1.37)	1.16 (0.99–1.34)	0.91 (0.78–1.06)
Adjusted MRRsa	1 (reference)	1.17 (1.01–1.36)	1.16 (1.00–1.34)	0.89 (0.76–1.03)
3 year
Survival	44% (41%–47%)	42% (39%–45%)	43% (40%–46%)	49% (46%–52%)b
MRRs	1 (reference)	1.07 (0.96–1.21)	1.04 (0.93–1.17)	0.88 (0.78–0.99)b
Adjusted MRRsa	1 (reference)	1.07 (0.95–1.20)	1.05 (0.94–1.18)	0.87 (0.77–0.98)b
5 year
Survival	35% (32%–38%)	33% (30%–36%)	35% (32%–38%)b	40% (37%–43%)b
MRRs	1 (reference)	1.08 (0.97–1.20)	1.03 (0.93–1.15)b	0.89 (0.80–0.99)b
Adjusted MRRsa	1 (reference)	1.08 (0.97–1.20)	1.05 (0.94–1.17)b	0.88 (0.79–0.99)b

Notes: The corresponding 95% confidence intervals are given in parentheses.

a Adjusted for age and gender;

b Predicted values.

Abbreviation: MRR, mortality rate ratio.

Figure 1 Overall survival in Danish invasive bladder cancer patients diagnosed in the period 1998–2009 in two of five Danish regions.

Table 2 1-, 3-, and 5-year survival in men with bladder cancer in the four time periods, examined by age

Men	Year of diagnosis
Age (years)	1998–2000	2001–2003	2004–2006	2007–2009
15–69
Number of cancer patients [%]	299 [39%]	252 [36%]	268 [37%]	299 [37%]
1-year survival	78% (73%–82%)	79% (73%–84%)	85% (80%–88%)	82% (77%–86%)
3-year survival	61% (55%–66%)	60% (54%–66%)	67% (61%–72%)	67% (61%–72%)a
5-year survival	55% (49%–60%)	52% (46%–58%)	58% (52%–64%)a	57% (51%–63%)a
70–79
Number of cancer patients [%]	293 [38%]	258 [37%]	275 [38%]	298 [37%]
1-year survival	74% (69%–79%)	66% (60%–72%)	65% (59%–70%)	77% (72%–82%)
3-year survival	46% (40%–52%)	45% (39%–51%)	42% (36%–48%)	48% (42%–54%)a
5-year survival	33% (28%–39%)	36% (30%–41%)	34% (29%–40%)a	39% (33%–45%)a
80+
Number of cancer patients [%]	181 [23%]	182 [26%]	186 [26%]	201 [26%]
1-year survival	51% (44%–58%)	48% (40%–55%)	45% (37%–52%)	57% (50%–63%)
3-year survival	25% (19%–31%)	24% (18%–30%)	22% (16%–28%)	30% (24%–37%)a
5-year survival	15% (11%–21%)	14% (10%–20%)	14% (9%–19%)a	19% (13%–26%)a

Notes: The corresponding 95% confidence interval is given in parentheses.

a Predicted values.

Table 3 1-, 3-, and 5-year survival in women with bladder cancer in the four time periods, examined by age

Women	Year of diagnosis
Age (years)	1998–2000	2001–2003	2004–2006	2007–2009
15–69
Number of cancer patients [%]	98 [38%]	102 [38%]	83 [35%]	88 [31%]
1-year survival	68% (58%–77%)	70% (60%–78%)	65% (54%–74%)	64% (53%–74%)
3-year survival	44% (34%–53%)	48% (38%–57%)	45% (34%–55%)	42% (31%–52%)a
5-year survival	42% (32%–51%)	40% (30%–49%)	39% (29%–50%)a	37% (27%–47%)a
70–79
Number of cancer patients [%]	87 [34%]	95 [35%]	83 [35%]	106 [38%]
1-year survival	56% (45%–66%)	55% (44%–64%)	60% (49%–70%)	72% (62%–80%)
3-year survival	31% (22%–41%)	39% (29%–49%)	42% (31%–52%)	52% (42%–61%)a
5-year survival	26% (18%–36%)	28% (20%–38%)	32% (22%–42%)a	40% (29%–50%)a
80+
Number of cancer patients [%]	70 [27%]	71 [26%]	70 [30%]	87 [31%]
1-year survival	49% (36%–60%)	31% (21%–42%)	30% (20%–41%)	43% (33%–54%)
3-year survival	24% (15%–35%)	8% (3%–16%)	14% (7%–23%)	31% (20%–42%)a
5-year survival	17% (9%–27%)	4% (1%–11%)	7% (2%–17%)a	18% (5%–36%)a

Notes: The corresponding 95% confidence interval is given in parentheses.

a Predicted values.